Cue Biopharma (CUE) Revenue (2018 - 2025)
Cue Biopharma (CUE) posted Revenue of $9.5 million for Q4 2025, up 342.07% sequentially from $2.1 million in Q3 2025, and up 502.79% YoY from $1.6 million in Q4 2024.
Cue Biopharma (CUE) Revenue (2018 - 2025) Analysis & Trends
Cue Biopharma has reported Revenue for 8 years, with the latest figure at $9.5 million in Q4 2025.
- Quarterly Revenue rose 502.79% year-over-year to $9.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.0 million (up 61.77% YoY) and the FY2025 annual result came in at $27.5 million, up 195.75% from the prior year.
- Revenue grew to $9.5 million in Q4 2025 per CUE's latest filing, from $2.1 million in the prior quarter.
- Over five years, Revenue peaked at $9.5 million in Q4 2025 and troughed at $26000.0 in Q2 2022.
- A 5-year average of $2.3 million and a median of $1.8 million in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue sank 99.05% in 2022, then jumped 5215.38% in 2023.
- Over 5 years, Revenue stood at $8.3 million in 2021, then slumped by 98.17% to $151000.0 in 2022, then jumped by 1105.96% to $1.8 million in 2023, then fell by 13.45% to $1.6 million in 2024, then jumped by 502.79% to $9.5 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $9.5 million, $2.1 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Cue Biopharma | 155.98 Mn | 138.56 Mn | - | 7.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.50 Mn |
| Sep 30, 2025 | 2.15 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 421,000.00 |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 187,000.00 |
| Dec 31, 2022 | 151,000.00 |
| Sep 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 8.25 Mn |
| Sep 30, 2021 | 2.40 Mn |
| Jun 30, 2021 | 2.74 Mn |
| Mar 31, 2021 | 1.55 Mn |